Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly for targeting cancer-related proteins. Shows potential in modulating signaling pathways involved in tumor growth and cell proliferation. Investigated for its role in improving selectivity and binding affinity in drug candidates for leukemia and solid tumors. Also employed in structure-activity relationship (SAR) studies to optimize potency and reduce off-target effects in new therapeutic agents.